FDA Clearance For I-STAT® BNP Test To Diagnose Congestive Heart Failure

... Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its i-STAT® BNP cartridge, a new point of care diagnostic test used to quickly assess the level of BNP (brain natriuretic peptide) in patients in emergency rooms, heart failure clinics and observation units, laboratories and other critical care settings. [click link for full article] ...